← All companies
BridgeBio Pharma, Inc.
BBIO - CIK 0001743881
Market cap$13.09 B
Rank#793
SEC filings777
The table below shows BridgeBio Pharma, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $570.12M | $681.10M | $375.94M | $376.69M | $393.77M | $356.08M |
| Short-term investments | - | - | $0.00 | $51.58M | $393.74M | $251.01M |
| Receivables | $139.44M | $4.72M | - | - | - | - |
| Inventory | $26.75M | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.